Desquamative Interstitial Pneumonitis (DIP) occurring during treatment with pegylated interferon and ribavirin

Respiratory Medicine CME

Volumn 2, Issue 2, 2009, Pages 77-79

  Calabrò, Elisa ^a   Zompatori, Maurizio ^b   Poletti, Venerino ^c   Olivieri, Dario ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

Desquamative Interstitial Pneumonitis; Pegylated interferon; Ribavirin

Indexed keywords

PEGINTERFERON ALPHA; PREDNISONE; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; DESQUAMATIVE INTERSTITIAL PNEUMONITIS; FIBEROPTIC BRONCHOSCOPY; HEPATITIS C; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG FUNCTION TEST; LUNG INFILTRATE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; TRANSBRONCHIAL BIOPSY;

EID: 64649096465     PISSN: 17550017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmedc.2008.10.010     Document Type: Article

References (5)

1. Manns M.P., McHutchison J.G., Gordon S.C., et al. Peginterferon alpha-2b plus ribavirin for the initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
2. Heathcote J.E., Shiffman M.L., Cooksley W.G.E., et al. Peginterferon alpha-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 343 (2000) 1673-1680
3. Yufu Y., Yamashita S., Nishimura J., et al. Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia. Am J Hematol 47 (1994) 253
4. Karim A., Ahmed S., Khan A., et al. Interstitial pneumonitis in a patient treated with alpha-interferon and ribavirin for hepatitis C infection. Am J Med Sci 322 (2001) 233-235
5. Kumar K.S., Russo M.W., Borczuk A.C., et al. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Am J Gastroenterol 97 (2002) 2432-2440